Troglitazone: proposed mechanisms of action. Troglitazone sensitizes... | Download Scientific Diagram
Handbook of Diabetes, 4th Edition, Excerpt #10: Management of Type 2 Diabetes
Thiazolidinediones Cause Cardiotoxicity via PPARγ- Independent Mechanism | IntechOpen
An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes - ScienceDirect
The mode of action of thiazolidinediones - Hauner - 2002 - Diabetes/Metabolism Research and Reviews - Wiley Online Library
Optimal diabetes control in adults. - ppt video online download
Oral hypoglycemic drugs
Figure 5 from Oral antihyperglycemic therapy for type 2 diabetes mellitus | Semantic Scholar
Mechanisms of Action of Troglitazone in the Prevention of High Glucose–Induced Migration and Proliferation of Cultured Coronary Smooth Muscle Cells
Paths between Troglitazone (label as PubChem ID: 5591) and PPARG with... | Download Scientific Diagram
Frontiers | A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies | Cell and Developmental Biology
![rosiglitazone [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/tzds.png "rosiglitazone [TUSOM | Pharmwiki]")
rosiglitazone [TUSOM | Pharmwiki]
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus | Nature Reviews Endocrinology
All-trans retinoic acid impairs glucose-stimulated insulin secretion by activating the RXR/SREBP-1c/UCP2 pathway | Acta Pharmacologica Sinica
Hyperglycemia - an overview | ScienceDirect Topics
Troglitazone activates TRPV1 and causes deacetylation of PPARγ in 3T3-L1 cells - ScienceDirect
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
The mode of action of thiazolidinediones - Hauner - 2002 - Diabetes/Metabolism Research and Reviews - Wiley Online Library
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors | Pharmacogenomics
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
